Journal article · 2026 · Open access

Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial

Pablo B. Nery, George A. Wells, Girish M. Nair, Vidal Essebag, Jacqueline E. Joza, Jorge A. Wong, George D. Veenhuyzen, Atul Verma, Isabelle Nault, Jason Andrade, John L. Sapp, Allan Cameron Skanes and 14 more

JAMA · Published 8 November 2026 · DOI 10.1001/jama.2026.24331

Open full textView at the publisherCite this paper

In brief

“Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial” is a 2026 journal article by Pablo B. Nery and 25 co-authors, published in JAMA. OpenAlex counts 0 citations as of 16 November 2026. It is open access: the full text is free to read at PubMed Central.

Citations
0
References
39
Authors
26

Abstract

Importance: Pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) has demonstrated modest success rates. Ablation of atrial low-voltage areas (LVA) has shown potential results, but more data are required. Objective: To determine whether PVI plus LVA ablation is superior to PVI alone in reducing atrial arrhythmia recurrence in patients with AF. Design, Setting, and Participants: Single-blind randomized clinical trial in 14 AF ablation centers in Canada. Adults with persistent AF of more than 3 months were enrolled between August 2018 and September 2024 and followed up for 18 to 36 months through April 2026. Intervention: Patients were randomized to PVI plus LVA ablation or PVI alone. Main Outcomes and Measures: The primary outcome was atrial arrhythmia recurrence beyond 90 days after a single catheter ablation procedure. Secondary outcomes included repeat ablation for AF, atrial flutter, or atrial tachycardia, emergency visits or hospitalization, arrhythmia recurrence over 18 months, procedure duration, total ablation delivery time, AF burden, and safety outcomes. The primary efficacy analysis was based on the modified intention-to-treat principle for patients who received the intervention. Results: Among 508 enrolled patients, 253 were randomized to PVI plus LVA ablation and 255 to PVI alone. Mean (SD) age was 65.2 (9.0) years, 386 (76%) were male and 268 (54%) had LVA. After a mean (SD) follow-up of 21 (15) months, 124 (49.4%) randomized to PVI plus LVA and 146 (57.5%) randomized to PVI reached the primary outcome (hazard ratio [HR], 0.82; 95% CI, 0.65-1.04; P = .11). In the prespecified principal subgroup analysis of 268 patients with LVA, arrhythmia recurrence occurred in 68 of 138 patients (49.3%) following PVI plus LVA ablation compared with 90 of 130 patients (69.2%) following PVI alone (HR, 0.77; 95% CI, 0.66-0.91; P = .002). Arrhythmia recurrence over 18 months (37.0% vs 56.2%; HR, 0.77; 95% CI, 0.64-0.92) and AF burden were lower after PVI plus LVA ablation in this group. Among patients without LVA, recurrence was similar between ablation groups (56 of 113 [49.6%] vs 51 of 113 [45.1%]; HR, 1.09; 95% CI, 0.90-1.32). Procedure duration and ablation delivery time were longer in the PVI plus LVA ablation group. Safety outcomes were similar between groups. Conclusions and Relevance: In this study, among patients with persistent AF, adjunctive LVA ablation did not significantly reduce atrial arrhythmia recurrence in the overall population over a mean 21-month follow-up. A prespecified principal subgroup analysis of patients with LVA suggested that adjunctive LVA ablation was consistent with reduced recurrence of atrial arrhythmias in this group. Trial Registration: ClinicalTrials.gov, Identifier: NCT03347227.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nery, P. B., Wells, G. A., Nair, G. M., Essebag, V., Joza, J. E., Wong, J. A., Veenhuyzen, G. D., Verma, A., Nault, I., Andrade, J., Sapp, J. L., Skanes, A. C., Golian, M., Macle, L., Sadek, M. M., Angaran, P., Sikkel, M. B., Dussault, C., Yung, D., . . . Birnie, D. H. (2026). Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2026.24331

MLA 9

Nery, Pablo B., et al. “Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial.” JAMA, 2026. https://doi.org/10.1001/jama.2026.24331.

Chicago

Nery, Pablo B., George A. Wells, Girish M. Nair, Vidal Essebag, Jacqueline E. Joza, Jorge A. Wong, George D. Veenhuyzen, et al. 2026. “Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial.” JAMA. https://doi.org/10.1001/jama.2026.24331.

Harvard

Nery, P. B. et al. (2026) ‘Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial’, JAMA. doi:10.1001/jama.2026.24331.

IEEE

P. B. Nery et al., “Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial,” JAMA, 2026, doi: 10.1001/jama.2026.24331.

BibTeX

@article{nery2026voltage,
  title     = {{Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial}},
  author    = {Nery, Pablo B. and Wells, George A. and Nair, Girish M. and Essebag, Vidal and Joza, Jacqueline E. and Wong, Jorge A. and Veenhuyzen, George D. and Verma, Atul and Nault, Isabelle and Andrade, Jason and Sapp, John L. and Skanes, Allan Cameron and Golian, Mehrdad and Macle, Laurent and Sadek, Mouhannad M. and Angaran, Paul and Sikkel, Markus Bernardus and Dussault, Charles and Yung, Derek and Healey, Jeff S. and Hansom, Simon Peter and Redpath, Calum J. and Redfearn, Damian and Ramirez, Francisco Daniel and Andres, Klein and Birnie, David H.},
  journal   = {JAMA},
  year      = {2026},
  doi       = {10.1001/jama.2026.24331},
  url       = {https://doi.org/10.1001/jama.2026.24331}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes

  • persistent atrial fibrillation
  • pulmonary vein isolation
  • low-voltage areas
  • catheter ablation
  • atrial arrhythmia recurrence
  • repeat ablation
  • atrial flutter
  • atrial tachycardia

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Nery, P. B., Wells, G. A., Nair, G. M., Essebag, V., Joza, J. E., Wong, J. A., Veenhuyzen, G. D., Verma, A., Nault, I., Andrade, J., Sapp, J. L., Skanes, A. C., Golian, M., Macle, L., Sadek, M. M., Angaran, P., Sikkel, M. B., Dussault, C., Yung, D., . . . Birnie, D. H. (2026). Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2026.24331

How many times has this paper been cited?

0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Pablo B. Nery, George A. Wells, Girish M. Nair, Vidal Essebag, Jacqueline E. Joza, Jorge A. Wong, George D. Veenhuyzen, Atul Verma, Isabelle Nault, Jason Andrade, John L. Sapp, Allan Cameron Skanes and 14 more.

What is the DOI of this paper?

10.1001/jama.2026.24331, permanently at https://doi.org/10.1001/jama.2026.24331. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.